[1]Dasari A, Shen C, Halperin D, et al. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the UnitedStates[J]. JAMA Oncol,2017,3(10):1335-1342.
[2]Zhou C, Zhang J, Zheng Y, et al. Pancreatic neuroendocrine tumors: a comprehensive review[J]. Int J Cancer,2012,131(5):1013-1022.
[3]Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an InternationalAgency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal[J]. Mod Pathol,2018,31(12):1770-1786.
[4]Ohmoto A, Rokutan H, Yachida S. Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current TreatmentStrategiesand Prospects for the Future[J]. Int J Mol Sci,2017,18(1):143. doi: 10.3390/ijms18010143.
[5]Cives M, Strosberg JR. Gastroenteropancreatic NeuroendocrineTumors[J]. CA Cancer J Clin,2018,68(6):471-487.
[6]Awe AM, Rendell VR, Lubner MG, et al. Texture Analysis: An Emerging Clinical Tool for Pancreatic Lesions[J]. Pancreas,2020,49(3):301-312.
[7]彭娜,秘建威,赵东强. 超声内镜在胰腺神经内分泌肿瘤诊治中的进展[J]. 中华超声影像学杂志,2020,29(1):87-90.
[8]Hewitt MJ, Mcphail MJ, Possamai L, et al. EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis[J]. Gastrointest Endosc,2012,75(2):319-331.
[9]Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They AreData[J]. Radiology,2016,278(2):563-577.
[10]宋涛,陆建平,张倩雯. 人工智能医学影像技术在胰腺神经内分泌肿瘤分级中的应用[J]. 第二军医大学学报,2020,41(4):433-438.
[11]Inzani F, Petrone G, Rindi G. The New World Health Organization Classification for Pancreatic Neuroendocrine Neoplasia[J]. Endocrinol Metab Clin North Am,2018,47(3):463-470.
[12]李斯婕,曹凯,陆建平. 胰腺神经内分泌瘤的CT与MRI影像特征[J]. 医学研究生学报,2016,29(8):853-857.
[13]宋茜,王化,孙琳,等. 胰腺神经内分泌肿瘤的多层螺旋CT表现及与不同病理分级的相关性[J]. 中国医学影像学杂志,2017,25(11):807-810.
[14]Kim DW, Kim HJ, Kim KW, et al. Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour[J]. Eur Radiol,2015,25(5):1375-1383.
[15]Belousova E, Karmazanovsky G, Kriger A, et al. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumourgrades[J]. Clin Radiol,2017,72(2):150-158.
[16]Gu D, Hu Y, Ding H, et al. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study[J]. Eur Radiol,2019,29(12):6880-6890.
[17]Canellas R, Burk KS, Parakh A, et al. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis[J]. AJR Am J Roentgenol,2018,210(2):341-346.
[18]Auernhammer CJ, Spitzweg C, Angele MK, et al. Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies[M]. 2018:404-415.
[19]傅德良,李恒超. 胰腺神经内分泌肿瘤诊治要点[J]. 肝胆外科杂志,2020,28(3):174-178.
[20]许朱定,张海斌,沈翔,等. 胰十二指肠切除术198例疗效分析[J]. 东南国防医药,2013,15(5):436-438.